StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.32−0.33 (-0.64%)

Close on Nov 18, 2026Market cap $7.13BP/E –Yield –

Cytokinetics net income

Net income is the profit left for shareholders after every expense, interest and tax.

Cytokinetics's net income for the twelve months ending Jun 30, 2026 was -$894.00M. For fiscal 2025 it was -$784.96M. The highest annual figure on record is $24.54M in fiscal 2009.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$784.96M–
FY2024Dec 31, 2024-$589.53M–
FY2023Dec 31, 2023-$526.24M–
FY2022Dec 31, 2022-$388.96M–
FY2021Dec 31, 2021-$215.31M–
FY2020Dec 31, 2020-$127.29M–
FY2019Dec 31, 2019-$121.69M–
FY2018Dec 31, 2018-$106.29M–
FY2017Dec 31, 2017-$127.79M-876.7%
FY2016Dec 31, 2016$16.45M–
FY2015Dec 31, 2015-$37.50M–
FY2014Dec 31, 2014-$14.65M–
FY2013Dec 31, 2013-$33.72M–
FY2012Dec 31, 2012-$40.37M–
FY2011Dec 31, 2011-$47.86M–
FY2010Dec 31, 2010-$49.29M-300.8%
FY2009Dec 31, 2009$24.54M–
FY2008Dec 31, 2008-$56.37M–
FY2007Dec 31, 2007-$48.89M–
FY2006Dec 31, 2006-$57.12M–
FY2005Dec 31, 2005-$42.25M–
FY2004Dec 31, 2004-$37.20M–
FY2003Dec 31, 2003-$32.69M–
FY2002Dec 31, 2002-$23.08M–
FY2001Dec 31, 2001-$15.87M–
FY2000Dec 31, 2000-$13.08M–
FY1999Dec 31, 1999-$7.34M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$198.76M–
Q1 FY2026Mar 31, 2026-$206.03M–
Q4 FY2025Dec 31, 2025-$183.03M–
Q3 FY2025Sep 30, 2025-$306.18M–
Q2 FY2025Jun 30, 2025-$134.37M–
Q1 FY2025Mar 31, 2025-$161.38M–
Q4 FY2024Dec 31, 2024-$150.02M–
Q3 FY2024Sep 30, 2024-$160.55M–
Q2 FY2024Jun 30, 2024-$143.32M–
Q1 FY2024Mar 31, 2024-$135.64M–
Q4 FY2023Dec 31, 2023-$136.90M–
Q3 FY2023Sep 30, 2023-$129.42M–
Q2 FY2023Jun 30, 2023-$128.64M–
Q1 FY2023Mar 31, 2023-$131.29M–
Q4 FY2022Dec 31, 2022-$137.38M–
Q3 FY2022Sep 30, 2022-$142.31M–
Q2 FY2022Jun 30, 2022-$19.82M–
Q1 FY2022Mar 31, 2022-$89.45M–
Q4 FY2021Dec 31, 2021-$30.57M–
Q3 FY2021Sep 30, 2021-$76.09M–
Q2 FY2021Jun 30, 2021-$61.55M–
Q1 FY2021Mar 31, 2021-$47.10M–
Q4 FY2020Dec 31, 2020-$43.93M–
Q3 FY2020Sep 30, 2020-$3.18M–
Q2 FY2020Jun 30, 2020-$40.78M–
Q1 FY2020Mar 31, 2020-$39.41M–
Q4 FY2019Dec 31, 2019-$30.64M–
Q3 FY2019Sep 30, 2019-$29.57M–
Q2 FY2019Jun 30, 2019-$32.11M–
Q1 FY2019Mar 31, 2019-$29.37M–
Q4 FY2018Dec 31, 2018-$26.47M–
Q3 FY2018Sep 30, 2018-$22.02M–
Q2 FY2018Jun 30, 2018-$27.52M–
Q1 FY2018Mar 31, 2018-$30.28M–
Q4 FY2017Dec 31, 2017-$40.48M-665.7%
Q3 FY2017Sep 30, 2017-$32.36M-197.0%
Q2 FY2017Jun 30, 2017-$29.08M–
Q1 FY2017Mar 31, 2017-$25.87M–
Q4 FY2016Dec 31, 2016$7.16M–
Q3 FY2016Sep 30, 2016$33.36M–

More Cytokinetics figures

See a number that looks wrong?